NIH Funding · FY2024
Total Funding
$670.8K
Fiscal year 2024
Grants Awarded
2
Active NIH grants
National Rank
#23,348
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $670.8K across 2 grants · National rank #23348.
Top grants by award amount
Aaron Cravens's NIH grant portfolio, ranked by award amount.
- 1R43GM154502-01R43An enzyme-based assay for the detection of carboxyethyl lysine-protein adducts$346.8Kaward amount
- 1R43DK137624-01A1R43Development of advanced glycation end product (AGE)-breaking enzymes as a novel therapy for the treatment of diabetic kidney disease$324Kaward amount
Affiliation
Institutions that have administered grants for Aaron Cravens.
Affiliated with Revel Pharmaceuticals Inc. (CA).
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardRevel Pharmaceuticals Inc.
- 2024$500K Cumulative Funding
Explore further
Find collaborators for Aaron Cravens
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at Revel Pharmaceuticals Inc.
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →